Reese Randle to Male
This is a "connection" page, showing publications Reese Randle has written about Male.
Connection Strength
0.872
-
Patel A, Lee CY, Sloan DA, Randle RW. Parathyroidectomy for Tertiary Hyperparathyroidism: A Multi-Institutional Analysis of Outcomes. J Surg Res. 2021 02; 258:430-434.
Score: 0.053
-
Randle RW, Ahle SL, Elfenbein DM, Hildreth AN, Lee CY, Greenberg JA, Schenarts PJ, Kempenich JW. Surgical Trainees' Sense of Responsibility for Patient Outcomes: A Multi-institutional Appraisal. J Surg Res. 2020 11; 255:58-65.
Score: 0.052
-
Jiang L, Lee CY, Sloan DA, Randle RW. Variation in the Quality of Thyroid Nodule Evaluations Before Surgical Referral. J Surg Res. 2019 12; 244:9-14.
Score: 0.048
-
Gan T, Huang B, Chen Q, Sinner HF, Lee CY, Sloan DA, Randle RW. Risk of Recurrence in Differentiated Thyroid Cancer: A Population-Based Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems. Ann Surg Oncol. 2019 Sep; 26(9):2703-2710.
Score: 0.047
-
Randle RW, Bates MF, Schneider DF, Sippel RS, Pitt SC. Survival in patients with medullary thyroid cancer after less than the recommended initial operation. J Surg Oncol. 2018 May; 117(6):1211-1216.
Score: 0.044
-
Randle RW, Bates MF, Long KL, Pitt SC, Schneider DF, Sippel RS. Impact of potassium iodide on thyroidectomy for Graves' disease: Implications for safety and operative difficulty. Surgery. 2018 01; 163(1):68-72.
Score: 0.043
-
Lowell AJ, Bushman NM, Wang X, Ma Y, Pitt SC, Sippel RS, Schneider DF, Randle RW. Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidism. J Surg Res. 2017 09; 217:252-257.
Score: 0.042
-
Randle RW, Bushman NM, Orne J, Balentine CJ, Wendt E, Saucke M, Pitt SC, Macdonald CL, Connor NP, Sippel RS. Papillary Thyroid Cancer: The Good and Bad of the "Good Cancer". Thyroid. 2017 07; 27(7):902-907.
Score: 0.042
-
Randle RW, Balentine CJ, Leverson GE, Havlena JA, Sippel RS, Schneider DF, Pitt SC. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery. 2017 01; 161(1):137-146.
Score: 0.040
-
Randle RW, Balentine CJ, Pitt SC, Schneider DF, Sippel RS. Selective Versus Non-selective a-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma. Ann Surg Oncol. 2017 Jan; 24(1):244-250.
Score: 0.040
-
Randle RW, Balentine CJ, Wendt E, Schneider DF, Chen H, Sippel RS. Should vitamin D deficiency be corrected before parathyroidectomy? J Surg Res. 2016 07; 204(1):94-100.
Score: 0.039
-
Randle RW, Swords DS, Levine EA, Fino NF, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Pawlik TM, Jin LX, Spolverato G, Schmidt C, Worhunsky D, Cho CS, Maithel SK, Votanopoulos KI. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative. J Surg Oncol. 2016 Jun; 113(7):750-5.
Score: 0.039
-
Randle RW, Griffith KF, Fino NF, Swett KR, Stewart JH, Shen P, Levine EA, Votanopoulos KI. Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res. 2015 Jun 15; 196(2):229-34.
Score: 0.036
-
Randle RW, Ahmed S, Levine EA, Fino NF, Swett KR, Stewart JH, Shen P, Votanopoulos KI. Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2015 May; 111(6):740-5.
Score: 0.035
-
Randle RW, Doud AN, Levine EA, Clark CJ, Swett KR, Shen P, Stewart JH, Votanopoulos KI. Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2015 May; 22(5):1634-8.
Score: 0.035
-
Randle RW, Levine EA, Clark CJ, Stewart JH, Shen P, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review. Am Surg. 2014 Jul; 80(7):710-3.
Score: 0.034
-
Randle RW, Ahmed S, Newman NA, Clark CJ. Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study. J Gastrointest Surg. 2014 Feb; 18(2):354-62.
Score: 0.033
-
Randle RW, Swett KR, Swords DS, Shen P, Stewart JH, Levine EA, Votanopoulos KI. Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites. Ann Surg Oncol. 2014 May; 21(5):1474-9.
Score: 0.032
-
Randle RW, Swett KR, Shen P, Stewart JH, Levine EA, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis. Am Surg. 2013 Jun; 79(6):620-4.
Score: 0.032
-
Sunwook K, Nussbaum MA, Quandt SA, Laurienti PJ, Arcury TA. Effects of Lifetime Occupational Pesticide Exposure on Postural Control Among Farmworkers and Non-Farmworkers. J Occup Environ Med. 2016 Feb; 58(2):133-9.
Score: 0.019
-
Oyler DR, Randle RW, Lee CY, Jenkins G, Chang PK, Sloan DA. Implementation of Opioid-Free Thyroid and Parathyroid Procedures: A Single Center Experience. J Surg Res. 2020 08; 252:169-173.
Score: 0.013
-
Bates MF, Lamas MR, Randle RW, Long KL, Pitt SC, Schneider DF, Sippel RS. Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease? Surgery. 2018 01; 163(1):118-123.
Score: 0.011
-
Imbus JR, Randle RW, Pitt SC, Sippel RS, Schneider DF. Machine learning to identify multigland disease in primary hyperparathyroidism. J Surg Res. 2017 11; 219:173-179.
Score: 0.011
-
Price AK, Randle RW, Schneider DF, Sippel RS, Pitt SC. Papillary thyroid microcarcinoma: decision-making, extent of surgery, and outcomes. J Surg Res. 2017 10; 218:237-245.
Score: 0.011
-
Votanopoulos KI, Russell G, Randle RW, Shen P, Stewart JH, Levine EA. Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases. Ann Surg Oncol. 2015 Apr; 22(4):1274-9.
Score: 0.009
-
Doud AN, Randle RW, Clark CJ, Levine EA, Swett KR, Shen P, Stewart JH, Votanopoulos KI. Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015 May; 22(5):1645-50.
Score: 0.009
-
Ahmed S, Levine EA, Randle RW, Swett KR, Shen P, Stewart JH, Votanopoulos KI. Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014 Dec; 21(13):4226-31.
Score: 0.009
-
Votanopoulos KI, Randle RW, Craven B, Swett KR, Levine EA, Shen P, Stewart JH, Mirzazadeh M. Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014 Mar; 21(3):868-74.
Score: 0.008
-
Votanopoulos KI, Swords DS, Swett KR, Randle RW, Shen P, Stewart JH, Levine EA. Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors. Ann Surg Oncol. 2013 Nov; 20(12):3899-904.
Score: 0.008